A method for monitoring antifibrinolytic therapy in patients with ruptured intracranial aneurysms

View More View Less
  • 1 Departments of Neurological Surgery and Laboratory Medicine, University of Washington, Seattle, Washington
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

✓ A rapid fluorometric assay technique has been utilized to assess the degree of fibrinolytic inhibition in 20 patients with ruptured intracranial aneurysms treated with epsilon-aminocaproic acid (EACA). This method quantitates the available plasminogen activity (APA) of plasma, and has proven to be a reliable means of monitoring antifibrinolytic therapy. Determination of the plasma APA also permits correlation of the level of fibrinolytic activity with putative complications of EACA therapy. Normal control plasma APA was 3.1 ± 0.7 CTA units/ml, but in patients with subarachnoid hemorrhage (SAH), pretreatment fibrinolytic activity was supranormal at 3.78 ± 0.88 CTA units/ml. During continuous intravenous administration of EACA (1.5 gm/hr) in patients with SAH, the plasma fibrinolytic activity was decreased to 0.9 ± 0.31 CTA units/ml. A case is described which exemplifies the use of this assay. In addition, an approach to monitoring antifibrinolytic therapy using the plasma APA is proposed.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address reprint requests to: Kim J. Burchiel, M.D., Department of Neurological Surgery, University of Washington, Seattle, Washington 98195.
  • 1.

    Alvarez Garijo JA, , Vilches JJ, & Aznar JA: Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity. J Neurosurg 52:453455, 1980 Alvarez Garijo JA, Vilches JJ, Aznar JA: Preoperative treatment of ruptured intracranial aneurysms with tranexamic acid and monitoring of fibrinolytic activity. J Neurosurg 52:453–455, 1980

    • Search Google Scholar
    • Export Citation
  • 2.

    Bergin JJ: The complications of therapy with epsilonaminocaproic acid. Med Clin North Am 50(6): 16691678, 1966 Bergin JJ: The complications of therapy with epsilonaminocaproic acid. Med Clin North Am 50(6):1669–1678, 1966

    • Search Google Scholar
    • Export Citation
  • 3.

    Britt CW, , Light RR, & Peters BH, et al: Rhabdomyolysis during treatment with epsilon-aminocaproic acid. Arch Neurol 37:187188, 1980 Britt CW, Light RR, Peters BH, et al: Rhabdomyolysis during treatment with epsilon-aminocaproic acid. Arch Neurol 37:187–188, 1980

    • Search Google Scholar
    • Export Citation
  • 4.

    Charyton C, & Purtilo D: Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N Engl J Med 280:11021104, 1969 Charyton C, Purtilo D: Glomerular capillary thrombosis and acute renal failure after epsilon-amino caproic acid therapy. N Engl J Med 280:1102–1104, 1969

    • Search Google Scholar
    • Export Citation
  • 5.

    DADE Protopath Procedure Manual. Miami, FL: American Hospital Supply Corp, 1979 DADE Protopath Procedure Manual. Miami, FL: American Hospital Supply Corp, 1979

    • Search Google Scholar
    • Export Citation
  • 6.

    Fearnley GR, , Balmforth G, & Fearnley E: Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. Clin Sci 16:645650, 1957 Fearnley GR, Balmforth G, Fearnley E: Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. Clin Sci 16:645–650, 1957

    • Search Google Scholar
    • Export Citation
  • 7.

    Geronemus R, , Herz DA, & Shulman K: Streptokinase clot lysis time in patients with ruptured intracranial aneurysms. J Neurosurg 40:499503, 1974 Geronemus R, Herz DA, Shulman K: Streptokinase clot lysis time in patients with ruptured intracranial aneurysms. J Neurosurg 40:499–503, 1974

    • Search Google Scholar
    • Export Citation
  • 8.

    Gibbs JR, & O'Gorman P: Fibrinolysis in subarachnoid haemorrhage. Postgrad Med J 43:779784, 1967 Gibbs JR, O'Gorman P: Fibrinolysis in subarachnoid haemorrhage. Postgrad Med J 43:779–784, 1967

    • Search Google Scholar
    • Export Citation
  • 9.

    Gralnick HR, & Greipp P: Thrombosis with epsilon aminocaproic acid therapy. Am J Clin Pathol 56:151154, 1971 Gralnick HR, Greipp P: Thrombosis with epsilon aminocaproic acid therapy. Am J Clin Pathol 56:151–154, 1971

    • Search Google Scholar
    • Export Citation
  • 10.

    MacKay AR, , U HS, & Weinstein PR: Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases. J Neurosurg 49:597601, 1978 MacKay AR, U HS, Weinstein PR: Myopathy associated with epsilon-aminocaproic acid (EACA) therapy. Report of two cases. J Neurosurg 49:597–601, 1978

    • Search Google Scholar
    • Export Citation
  • 11.

    McKay DG, & Müller-Berghaus G: Therapeutic implications of disseminated intravascular coagulation. Am J Cardiol 20:392410, 1967 McKay DG, Müller-Berghaus G: Therapeutic implications of disseminated intravascular coagulation. Am J Cardiol 20:392–410, 1967

    • Search Google Scholar
    • Export Citation
  • 12.

    McNicol GP, , Fletcher AP, & Alkjaersig N, et al: The absorption, distribution, and excretion of ϵ-aminocaproic acid following oral or intravenous administration to man. J Lab Clin Med 59:1524, 1962 McNicol GP, Fletcher AP, Alkjaersig N, et al: The absorption, distribution, and excretion of ϵ-aminocaproic acid following oral or intravenous administration to man. J Lab Clin Med 59:15–24, 1962

    • Search Google Scholar
    • Export Citation
  • 13.

    McNicol GP, , Fletcher AP, & Alkjaersig N, et al: The use of epsilon aminocaproic acid, a potent inhibitor of fibrinolytic activity, in the management of postoperative hematuria. J Urol 86:829837, 1961 McNicol GP, Fletcher AP, Alkjaersig N, et al: The use of epsilon aminocaproic acid, a potent inhibitor of fibrinolytic activity, in the management of postoperative hematuria. J Urol 86:829–837, 1961

    • Search Google Scholar
    • Export Citation
  • 14.

    Mullan S, & Dawley J: Antifibrinolytic therapy for intracranial aneurysms. J Neurosurg 28:2123, 1968 Mullan S, Dawley J: Antifibrinolytic therapy for intracranial aneurysms. J Neurosurg 28:21–23, 1968

    • Search Google Scholar
    • Export Citation
  • 15.

    Naeye RL: Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocaproic acid. Blood 19:694701, 1962 Naeye RL: Thrombotic state after a hemorrhagic diathesis, a possible complication of therapy with epsilon-aminocaproic acid. Blood 19:694–701, 1962

    • Search Google Scholar
    • Export Citation
  • 16.

    Nibbelink DW: Antifibrinolytic activity during administration of epsilon-aminocaproic acid. Stroke 2:555558, 1971 Nibbelink DW: Antifibrinolytic activity during administration of epsilon-aminocaproic acid. Stroke 2:555–558, 1971

    • Search Google Scholar
    • Export Citation
  • 17.

    Nibbelink DW, , Torner JC, & Henderson WG: Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage. Stroke 6:622629, 1975 Nibbelink DW, Torner JC, Henderson WG: Intracranial aneurysms and subarachnoid hemorrhage. A cooperative study. Antifibrinolytic therapy in recent onset subarachnoid hemorrhage. Stroke 6:622–629, 1975

    • Search Google Scholar
    • Export Citation
  • 18.

    Nilsson IM, , Andersson L, & Björkman SE: Epsilonaminocaproic acid (EACA) as a therapeutic agent based on 5 years' clinical experience. Acta Med Scand (Suppl 448): 146, 1966 Nilsson IM, Andersson L, Björkman SE: Epsilonaminocaproic acid (EACA) as a therapeutic agent based on 5 years' clinical experience. Acta Med Scand (Suppl 448):1–46, 1966

    • Search Google Scholar
    • Export Citation
  • 19.

    Norlén G, & Thulin C-A: The use of antifibrinolytic substances in ruptured intracranial aneurysms. Neurochirurgia 12:100102, 1969 Norlén G, Thulin C-A: The use of antifibrinolytic substances in ruptured intracranial aneurysms. Neurochirurgia 12:100–102, 1969

    • Search Google Scholar
    • Export Citation
  • 20.

    Park BE: Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: epsilonaminocaproic acid as a possible predisposing factor. Surg Neurol 11:7380, 1979 Park BE: Spontaneous subarachnoid hemorrhage complicated by communicating hydrocephalus: epsilonaminocaproic acid as a possible predisposing factor. Surg Neurol 11:73–80, 1979

    • Search Google Scholar
    • Export Citation
  • 21.

    Pechet L: Fibrinolysis. N Engl J Med 273:10241034, 1965 Pechet L: Fibrinolysis. N Engl J Med 273:1024–1034, 1965

  • 22.

    Pochron SP, , Mitchell GA, & Albareda I, et al: A fluorescent substrate assay for plasminogen. Thromb Res 13:733739, 1978 Pochron SP, Mitchell GA, Albareda I, et al: A fluorescent substrate assay for plasminogen. Thromb Res 13:733–739, 1978

    • Search Google Scholar
    • Export Citation
  • 23.

    Ransohoff J, , Goodgold A, & Benjamin MV: Preoperative management of patients with ruptured intracranial aneurysms. J Neurosurg 36:525530, 1972 Ransohoff J, Goodgold A, Benjamin MV: Preoperative management of patients with ruptured intracranial aneurysms. J Neurosurg 36:525–530, 1972

    • Search Google Scholar
    • Export Citation
  • 24.

    Raum D, , Marcus D, & Alper CA, et al: Synthesis of human plasminogen by the liver. Science 208:10361037, 1980 Raum D, Marcus D, Alper CA, et al: Synthesis of human plasminogen by the liver. Science 208:1036–1037, 1980

    • Search Google Scholar
    • Export Citation
  • 25.

    Schisano G: Antifibrinolytics in the treatment of subarachnoid hemorrhage due to rupture of arterial aneurysm. J Neurosurg Sci 18:3946, 1974 Schisano G: Antifibrinolytics in the treatment of subarachnoid hemorrhage due to rupture of arterial aneurysm. J Neurosurg Sci 18:39–46, 1974

    • Search Google Scholar
    • Export Citation
  • 26.

    Sengupta RP, , So SC, & Villarejo-Ortega FJ: Use of epsilon aminocaproic acid (EACA) in the preoperative management of ruptured intracranial aneurysms. J Neurosurg 44:479484, 1976 Sengupta RP, So SC, Villarejo-Ortega FJ: Use of epsilon aminocaproic acid (EACA) in the preoperative management of ruptured intracranial aneurysms. J Neurosurg 44:479–484, 1976

    • Search Google Scholar
    • Export Citation
  • 27.

    Smith RR, & Upchurch JJ: Monitoring antifibrinolytic therapy in subarachnoid hemorrhage. J Neurosurg 38:339344, 1973 Smith RR, Upchurch JJ: Monitoring antifibrinolytic therapy in subarachnoid hemorrhage. J Neurosurg 38:339–344, 1973

    • Search Google Scholar
    • Export Citation
  • 28.

    Sonntag VKH, & Stein BM: Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acid. J Neurosurg 40:480485, 1974 Sonntag VKH, Stein BM: Arteriopathic complications during treatment of subarachnoid hemorrhage with epsilon-aminocaproic acid. J Neurosurg 40:480–485, 1974

    • Search Google Scholar
    • Export Citation
  • 29.

    Stamm H, , Caflisch A, & Mall M: Diagnose und therapie der afibrinoganie postpartum. Gynaecologia (Basel) 156:1217, 1963 Stamm H, Caflisch A, Mall M: Diagnose und therapie der afibrinoganie postpartum. Gynaecologia (Basel) 156:12–17, 1963

    • Search Google Scholar
    • Export Citation
  • 30.

    Tovi D: The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage. Acta Neurol Scand 49:163175, 1973 Tovi D: The use of antifibrinolytic drugs to prevent early recurrent aneurysmal subarachnoid haemorrhage. Acta Neurol Scand 49:163–175, 1973

    • Search Google Scholar
    • Export Citation
  • 31.

    Tovi D, & Nilsson IM: Increased fibrinolytic activity and fibrin degradation products after experimental intracerebral haemorrhage. Acta Neurol Scand 48:403415, 1972 Tovi D, Nilsson IM: Increased fibrinolytic activity and fibrin degradation products after experimental intracerebral haemorrhage. Acta Neurol Scand 48:403–415, 1972

    • Search Google Scholar
    • Export Citation
  • 32.

    Tovi D, & Thulin CA: Ability of tranexamic acid to cross the blood-brain barrier and its use in patients with ruptured intracranial aneurysms. Acta Neurol Scand 48:257, 1972 (Summary) Tovi D, Thulin CA: Ability of tranexamic acid to cross the blood-brain barrier and its use in patients with ruptured intracranial aneurysms. Acta Neurol Scand 48:257, 1972 (Summary)

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 353 146 7
Full Text Views 194 2 0
PDF Downloads 51 1 0
EPUB Downloads 0 0 0